Clinical Trial Update: Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GnRHa to protect ovarian function during chemotherapy-induced gonadotoxicity in breast cancer patients; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist

Snippet

Sponsor: Xiangyun Zong | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-05-03